quinoxalines has been researched along with trifluoroacetic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Flückiger, R; Gallop, PM; Greenspan, SL; Henson, E; Paz, MA | 1 |
Aburada, M; Aoki, K; Hattori, T; Hirokawa, H; Koseki, J; Miyamoto, K; Mori, Y; Niitsu, K; Obata, T; Takeda, S; Yamazaki, Y | 1 |
Bhosale, RS; Bhosale, SV; More, YW; Padghan, SD; Pawar, RP; Puyad, AL | 1 |
Li, YN; Wang, Z; Wu, JB; Zeng, YF; Zhou, MX | 1 |
4 other study(ies) available for quinoxalines and trifluoroacetic acid
Article | Year |
---|---|
Acid-promoted tautomeric lactonization and oxidation-reduction of pyrroloquinoline quinone (PQQ).
Topics: Chemical Phenomena; Chemistry; Coenzymes; Hydrolysis; Indicators and Reagents; Isomerism; Lactones; Mass Spectrometry; Oxidation-Reduction; PQQ Cofactor; Quinolones; Quinoxalines; Trifluoroacetic Acid | 1989 |
Potent platelet-derived growth factor-beta receptor (PDGF-betaR) inhibitors: Synthesis and structure-activity relationships of 7-[3-(cyclohexylmethyl)ureido]-3-{1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one derivatives.
Topics: Catalysis; Enzyme Inhibitors; ErbB Receptors; Hepatocyte Growth Factor; Humans; Inhibitory Concentration 50; Manganese Compounds; Oxidation-Reduction; Oxides; Protein-Tyrosine Kinases; Quinoxalines; Receptor, IGF Type 1; Receptor, Platelet-Derived Growth Factor beta; Structure-Activity Relationship; Trifluoroacetic Acid | 2007 |
Proton Triggered Colorimetric and Fluorescence Response of a Novel Quinoxaline Compromising a Donor-Acceptor System.
Topics: Color; Colorimetry; Electrochemistry; Ethylamines; Fluorescent Dyes; Hydrogen-Ion Concentration; Nitriles; Protons; Quinoxalines; Reagent Strips; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Trifluoroacetic Acid | 2018 |
Tandem reduction and trifluoroethylation of quinolines and quinoxalines with trifluoroacetic acid and trimethylamine borane.
Topics: Boranes; Quinolines; Quinoxalines; Trifluoroacetic Acid | 2022 |